The breakthrough discovery of RNA interference that earned UMass Medical School Professor Craig C. Mello, PhD, and Andrew Z. Fire, PhD, of Stanford University, the 2006 Nobel Prize in Medicine is yielding its first commercial drug, and possibly a new class of drugs, according to numerous media reports, including stories in Stat News, Forbes and Worcester Business Journal.
The U.S. Food and Drug Administration recruited Patricia Franklin, MD, MBA, MPH, for her expertise in patient-reported outcomes to help determine how mobile health apps and wearables can be used to evaluate the performance and safety of implantable medical devices.
A study conducted by Benjamin Nwosu, MD, at UMass Medical School has confirmed the accuracy of a new, simple method to determine whether children newly diagnosed with type 1 diabetes are experiencing a beneficial partial clinical remission.
Chancellor Michael F. Collins and Mark S. Klempner, MD, executive vice chancellor for MassBiologics at UMass Medical School, provided a tour of the MassBiologics facility on Monday, Sept. 18 to local lawmakers and discussed a promising gene therapy treatment underway, according to an article in the Standard Times.
At the Graduate School of Biomedical Sciences Recognition Ceremony on Sept. 14, Dean Anthony Carruthers, PhD, reflected upon his aspirations for the 52 graduate students who are entering the “proving ground for doctoral study.”
At the 2017 Investiture Ceremony following Convocation on Wednesday, Sept., 13, nine distinguished faculty members were officially invested into named professorships, bringing the total number of endowed chairs at UMass Medical School to 48.
Marian Walhout, PhD, has received a 5-year, $4.1 million Maximizing Investigators’ Research Award from the National Institutes of Health to continue her study of metabolism and gene expression and how they interact.
A new UMass Medical School study of international volunteering among American plastic surgeons co-authored by Joyce McIntyre, MD, is the first to delve into the effectiveness and quality of American surgery missions around the globe.
New research by Hemant Khanna, PhD, and colleagues in the Horae Gene Therapy Center at UMass Medical School explores gene therapy to treat the most common form of Leber congenital amaurosis, a severe inherited disorder that causes childhood blindness.
People who are overweight or obese and undergo total joint replacement experience the same pain relief as those patients who do so at a lower body weight, according to a study by UMass Medical School that is being reported in media outlets across the country.